You are here: Home » Companies » News
Business Standard

Sun Pharma arm gets relief from US court in patent infringement case

Earlier this year, DUSA, which is wholly-owned by Sun Pharma, filed a lawsuit against the Biofrontera defendants in the US District Court for the District of Massachusetts

Press Trust of India  |  New Delhi 

Sun Pharma

Wednesday said its arm has received relief from a in a patent

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said in a regulatory filing.

Earlier this year, DUSA, which is wholly-owned by Sun Pharma, filed a lawsuit against the Biofrontera defendants in the US District Court for the District of Massachusetts.

ALSO READ: Sebi probes whistleblower complaint against Sun Pharma; shares tumble 3%

The lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.

DUSA, in its amended complaint filed in July 2018, additionally alleged the Biofrontera defendants misappropriated confidential and trade secret information by obtaining confidential information from its former employees to sell and market defendants' own products.

The lawsuit sought an assessment of both damages and injunctive relief against the Biofrontera defendants, said.

ALSO READ: Meet Sudhir Valia, Sun Pharma's director, one of India's prolific investors

The court's order prohibits Biofrontera from making use of or disseminating DUSA's sales and financial information, customer lists and customer target lists, training and marketing materials, standard operating procedures, technical information, and unpublished clinical data, and any derivations thereof, effective immediately, it added.

shares Wednesday ended 2.23 per cent down at Rs 414 apiece on the BSE.

First Published: Wed, December 26 2018. 17:35 IST
RECOMMENDED FOR YOU